tiprankstipranks
The Fly

Insmed 12.6M share Secondary priced at $51.50

Insmed 12.6M share Secondary priced at $51.50

The deal size was increased to $650M in common stock from $500M in common stock. Goldman Sachs and Leerink acted as joint book running managers for the offering.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com